RELL

The investment thesis is based on a V-shaped recovery in the high-margin semiconductor wafer business, with projected 100% revenue growth from $20M to $40M. The Green Energy Solutions (GES) segment is also a key driver, with double-digit growth expected from secular trends like grid modernization and wind energy. The recent divestiture of the unprofitable Healthcare unit is seen as a positive catalyst, removing a margin drag. The stock is considered undervalued, trading at less than 1x sales and tangible book value.

The article highlights the cyclical downturn in the semiconductor business (PMT segment) as a transitory headwind that has caused the stock to be oversold. The author sees a "V" shaped recovery in the semi-wafer customer demand in the first half of CY 2024. The Green Energy Solutions (GES) segment, particularly the EV locomotive business with Progress Rail, is identified as a significant growth driver. The turnaround of the Healthcare segment to profitability is another key catalyst. The author forecasts a conservative EPS of $0.80 for FY 2024, a significant decrease from FY 2023, but believes the long-term opportunity is attractive.

The thesis is driven by the fast-growing, higher-margin Green Energy Solutions (GES) segment. The company is seen as a misunderstood "demand dust" business with a venture portfolio of products. The author believes the company's operations have reached an inflection point for sustainable revenue growth and profitability. The base case suggests a fair value of $25 per share and a price target of $45 by FY27, driven by 11% revenue growth. The author acknowledges governance concerns due to the CEO's controlling stake but believes the secular trends and growing backlog offer significant upside.